Variant report
Variant | esv3436481 |
---|---|
Chromosome Location | chr12:46427785-46431983 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr12:46424597..46426625-chr12:46428577..46431256,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs544628503 | chr12:46427874-46427875 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs561309343 | chr12:46427903-46427904 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs185362231 | chr12:46427906-46427907 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs540400493 | chr12:46427915-46427916 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs542617615 | chr12:46427956-46427957 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs139537921 | chr12:46427977-46427978 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs532613361 | chr12:46427988-46427989 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs190171386 | chr12:46428012-46428013 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs569217058 | chr12:46428078-46428079 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs371621457 | chr12:46428122-46428123 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs7305576 | chr12:46428129-46428130 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs550157791 | chr12:46428135-46428136 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs367776268 | chr12:46428150-46428151 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs146631073 | chr12:46428156-46428157 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs536328443 | chr12:46428166-46428167 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs552806862 | chr12:46428186-46428187 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs111969369 | chr12:46428188-46428189 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs78742885 | chr12:46428217-46428218 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs558852633 | chr12:46428262-46428263 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs575604069 | chr12:46428282-46428283 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs544567186 | chr12:46428284-46428285 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs554981101 | chr12:46428311-46428312 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs543627070 | chr12:46428323-46428324 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs574775260 | chr12:46428344-46428345 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs182655731 | chr12:46428359-46428360 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs560405485 | chr12:46428391-46428392 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs149824498 | chr12:46428475-46428476 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs115349601 | chr12:46428505-46428506 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs543613961 | chr12:46428506-46428507 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs531862559 | chr12:46428655-46428656 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs370371168 | chr12:46428673-46428674 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs11514434 | chr12:46428674-46428675 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs529676975 | chr12:46428699-46428700 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs188576025 | chr12:46428720-46428721 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs566456071 | chr12:46428726-46428727 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs538781893 | chr12:46428727-46428728 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs558785367 | chr12:46428753-46428754 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs113067934 | chr12:46428804-46428805 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs113468210 | chr12:46428842-46428843 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs563762985 | chr12:46428852-46428853 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs532356859 | chr12:46428882-46428883 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs149048980 | chr12:46428886-46428887 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs554584199 | chr12:46428911-46428912 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs143082162 | chr12:46428926-46428927 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs147764770 | chr12:46428965-46428966 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs11561397 | chr12:46428974-46428975 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs577263699 | chr12:46428977-46428978 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs184016722 | chr12:46428997-46428998 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs111463538 | chr12:46429840-46429841 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs570484451 | chr12:46429868-46429869 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Seminomas | 18059402 | CNVD |
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Lissencephaly | 21572526 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Breast cancer | 19602461 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16272173 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Adenoid cystic carcinoma | 18332873 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 18632612 | CNVD |
Gastric cancer | 18160780 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Melanoma | 18172304 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
liposarcomas | 17372913 | CNVD |
Non-small cell lung cancer | 24170126 | CNVD |
Cancer | 16751803 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Bladder cancer | 21909424 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Breast cancer | 21542898 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Breast cancer | 17661082 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:46427200-46429000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr12:46428200-46428800 | Enhancers | Hela-S3 | cervix |
3 | chr12:46429800-46437400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr12:46430600-46431000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
5 | chr12:46430800-46431000 | Bivalent Enhancer | IMR90 fetal lung fibroblasts Cell Line | lung |
6 | chr12:46430800-46431400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
7 | chr12:46431000-46431400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |